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Pluripotent human embryonic stem (hES) cells can
differentiate into various cell types derived from the
three embryonic germ layers and extraembryonic tis-
sues such as trophoblasts. The mechanisms govern-
ing lineage choices of hES cells are largely unknown.
Here, we report that we established two independent
hES cell clones lacking a group of cell surface mole-
cules, glycosyl-phosphatidyl-inositol-anchored pro-
teins (GPI-APs). The GPI-AP deficiency in these two
hESclones isdue to thedeficiency in thegeneexpres-
sion of PIG-A (phosphatidyl-inositol-glycan class A),
which is required for the first step of GPI synthesis.
GPI-AP-deficient hES cells were capable of forming
embryoid bodies and initiating cell differentiation
into the three embryonic germ layers. However, GPI-
AP-deficient hES cells failed to form trophoblasts
after differentiation induction by embryoid body for-
mation or by adding exogenous BMP4. The defect in
trophoblast formation was due to the lack of GPI-an-
chored BMP coreceptors, resulting in the impairment
of full BMP4 signaling activation in the GPI-AP-defi-
cient hES cells. These data reveal that GPI-AP-en-
hanced full activation of BMP signaling is required
for human trophoblast formation.
INTRODUCTION
PIG-A is required for the first step in GPI anchor biosynthesis (Ki-
noshita et al., 1997). The human (X chromosome-linked) PIG-A
gene is found mutated in hematopoietic stem cells (HSCs) of pa-
tients with paroxysmal nocturnal hemoglobinuria (PNH), a clonal
disorder of the blood system that causes intravascular hemoly-
sis, venous thrombosis, and bone marrow failure (Takeda et al.,
1993; Luzzatto et al., 1997; Kinoshita et al., 1997; Dunn et al.,
1999). Inactivation of PIG-A in HSCs results in the lack ofall GPI-APs, including two complement inhibitors CD55
and CD59; the lack of these two cell surface proteins explains
the complement-mediated intravascular hemolysis associated
with PNH.However, other clinical features of PNH, such as clonal
expansion and the associated bone marrow failure, remain
poorly understood (Kinoshita et al., 1997; Luzzatto et al., 1997;
Dunn et al., 1999). Members of dozens of GPI-APs function as
coreceptors, coligands, ectoenzymes, and cell adhesion mole-
cules (Kinoshita et al., 1997; Minchiotti et al., 2000; Chesebro
et al., 2005). The importance of the GPI anchor moiety in linking
the protein to the cell membrane has been demonstrated for
several GPI-APs (Minchiotti et al., 2000; Chesebro et al., 2005).
To establish a prospective experimental system for PNH, a so-
matic disease, mouse models have been established by disrupt-
ing the Pig-a gene in mouse ES (mES) cells (Dunn et al., 1996;
Rosti et al., 1997; Keller et al., 2001). Although the Pig-a gene
(also X-linked) is dispensable for the growth of undifferentiated
mES cells in culture, the inactivation of the mouse Pig-a gene
is embryonic lethal (Rosti et al., 1997; Keller et al., 2001). Condi-
tional Pig-a null mice lacking GPI-APs in all the lineages of blood
and immune cells were later achieved (Keller et al., 2001). How-
ever, these mice have a normal life span and do not recapitulate
the PNH symptoms seen in human patients. Because of the
current limited ability to expand human HSCs in culture that
are required for selecting and expanding rare clones after stable
geneticmodification, it has been impossible tomake aPIG-A null
mutation by knocking out or down the PIG-A gene in normal
human HSCs.
Our initial goal of this project was tomake PIG-A-deficient hES
cells that can be subsequently induced to differentiate into he-
matopoietic cells (Kaufman et al., 2001; Zhan et al., 2004; Lensch
and Daley, 2006), which may serve as a novel genetic model for
PNH. After trials with several methods, we established two inde-
pendent clones of hES cells lacking the expression of the PIG-A
gene and GPI-APs on hES cell surface. Although full character-
izations of these GPI-AP-deficient hES cells such as differentia-
tion to hematopoietic and other somatic lineages are still in prog-
ress, our data reveal an unexpected but critical role of GPI-APs
in potentiating cellular signaling by bone morphogenetic protein
4 (BMP4) and trophoblast development of hES cells.Cell Stem Cell 2, 345–355, April 2008 ª2008 Elsevier Inc. 345
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Human ES Cells Lack GPI-Anchored Surface ProteinsFigure 1. Analyses of Two hES Cell Clones
Lacking GPI-Anchored Proteins
After aerolysin selection, G-GFP-derived hES cells
that lacked GPI-APs were sorted and expanded.
Six clones were obtained from two large-scale ex-
periments. Two (AR1-c1 and AR2-c1) were further
characterized since they can form undifferentiated
colonies (Table S2). (A) Cell surface staining for
alkaline phosphatase (APase). The AR1-c1 or its
parental G-GFP hES cells (both constitutively ex-
pressing GFP) were cultured under a feeder-free
condition and fixed before cell surface staining.
Mouse monoclonal IgG recognizing either the
APase (Aa and Ab) or SSEA-4 (Ac and Ad) was
used as primary antibodies. Then, Alexa 555-con-
jugated antibodies recognizing anti-mouse IgG
were used to light up detected antigens. The mi-
crographic images of stained were superimposed
with that of cellular GFP signals. While both APase
and SSEA4 were detected on the cell surface of
G-GFP cells (Aa and Ac), only SSEA-4 (Ad), but
not the APase (Ab), was detected on AR1-c1 cells.
(B). Flow cytometric analysis of other GPI-APs,
such as CD90, CD55, CD59, and Cripto, using
PE-conjugated-specific IgGs. The red lines repre-
sent staining profiles of the G-GFP control,
whereas the green lines represent the AR1-c1
hES cells. The black lines represent the back-
ground staining (using irrelevant antibodies).
Both hES cell types expressed a high level of sur-
face marker SSEA3. (C) Similar analysis of the
AR2-c1 hES cell clone before or after transduction
by a lentiviral vector expressing a PIG-A trans-
gene. AR2-c1 cells express SSEA4, but lack
CD90, CD55, or CD59. After one round of trans-
duction, 80% AR2-c1 cells stably expressed
GPI-APs.RESULTS
Establishment of Clonal hES Cells Lacking GPI-APs
Consistent with previous studies, we found that several GPI-APs
such as alkaline phosphatase (APase), CD90/Thy1, and Cripto
are preferentially expressed on cell surface of undifferentiated
hES cells (Figure 1). The mRNA expression profile of known
GPI-AP genes in undifferentiated and differentiated hES cells is
provided in Table S1 available online. We have attempted sev-
eral approaches to knock out or down the X chromosome-linked
PIG-A gene in XY hES cell line such as H1. The most successful
approach to date was to use proaerolysin for counter selection of
cells lacking GPI-APs. Proaerolysin is a bacterial toxin that uses
GPI-APs as a cellular receptor. It is converted by cell surface pro-
teases to aerolysin that potently kills mammalian cells normally
expressing various GPI-APs (Brodsky et al., 1999; Hu et al.,
2005). Cells lacking GPI-APs such as PIG-A null mutants escape
aerolysin-mediated cell killing. We used the H1 hES cell popula-
tion that had been transduced by a GFP-expressing lentiviral
vector (Dravid et al., 2005; Zhou et al., 2007). After serial aeroly-
sin selections of these GFP-expressing hES cells (called G-GFP
thereafter), aerolysin-resistant (AR) hES cells lacking GPI-APs
were obtained from two independent batch selections. By limit-346 Cell Stem Cell 2, 345–355, April 2008 ª2008 Elsevier Inc.ing dilution, six independent AR hES cell cloneswere established
(Table S2). Clones that lack GPI-APs but can be restored by
PIG-A transgene expression were further expanded. One clone
from each batch selection, AR1-clone 1 (AR1-c1) or AR2-c1, re-
tained undifferentiated morphology after serial expansion and
was characterized (Figure 1).
We found that both AR clones completely lack GPI-APs such
as APase, CD90, CD55, CD59, and Cripto on cell surface (Fig-
ure 1), even though the protein portion was detected inside
hES cells (Figure S1). Both AR hES clones can maintain undiffer-
entiated morphology and express undifferentiated cell-surface
markers such as SSEA3 and SSEA4 that are not GPI-APs (Fig-
ure 1). Both AR clones have a similar proliferation rate as com-
pared to the parental G-GFP hES cells when cultured on feeder
cells or under feeder-free conditions (data not shown). GPI-APs
such as CD90, CD55, or CD59 can be restored by transduction
of a lentiviral vector expressing the PIG-A coding sequence
both in AR2-c1 (Figure 1C) and AR1-c1 cells (Zhou et al., 2007),
indicating that the GPI-AP deficiency is due to the absence of
PIG-A.
Once sufficient hES cells were obtained by expansion, both
clones were confirmed to have a normal karyotype (Figure S2).
The AR1-c1 clone is capable of maintaining a normal karyotype
Cell Stem Cell
Human ES Cells Lack GPI-Anchored Surface ProteinsFigure 2. Analysis of PIG-A Gene Expression in
Human ES Cells Lacking GPI-APs
(A) Conventional RT-PCR of the PIG-A gene expression in un-
differentiated ES cells (undiff. ES) and differentiated hES cells
after BMP4 induction or embryoid body formation (EB) after
10 days. G-GFP hES cells (samples 1) and AR1-c1 (samples
2) clonal hES cells were analyzed side by side. In addition, we
analyzed reconstituted AR1-c1 hES cells after transduction of
PIG-A transgene that restored GPI-AP expression (sample 3).
(B) Similar analysis of AR2-c1hEScells (sample 4) and the AR2-
c1 cells restored by thePIG-A transgeneexpression (sample 5).
(C) Quantitative RT-PCR analysis of the PIG-A gene in AR1-c1
hES cells before and after differentiation. The relative level of
PIG-A mRNA is first normalized by that of beta-actin and then
by the level in teratoma (defined as 100), which was used as
a common positive control in quantitative RT-PCR analyses.
The mean and SD (n = 4) were plotted in a log scale. The PIG-
AmRNA in undifferentiated G-GFP cells is found at a low level
(1% to 2%of teratoma), but elevated significantly after differen-
tiation by BMP4 induction or EB formation (A, C, and D). Nota-
bly, the PIG-AmRNA level in undifferentiated AR1-c1 hES cells
(sample 2) and AR2-c1 (sample 4) was much lower (10 fold)
than the control G-GFP cells by both assays in (A–C). The defi-
ciency ofPIG-AmRNA in AR1-c1cells ismore obvious after dif-
ferentiation (A and C).
(D) Northern blot ofPIG-AmRNA in AR1-c1 cells confirmedRT-
PCR data that the PIG-A deficiency is due to the lack of PIG-A
mRNA.Cell Stem Cell 2, 345–355, April 2008 ª2008 Elsevier Inc. 347over 2 years, although karyotypically abnormal cells occasionally
arise. The AR2-c1 clone gained an extra Chromosome 12 in
a small fraction (2/20) initially soon after clonal derivation. As
happens often with wild-type hES cells after prolonged culture
(Draper et al., 2004), mutated AR2-c1 cells that gain selective
growth advantage soon took over the whole population and ac-
quired additional mutations. Early-passage AR2-c1 cells with or
without an extra chromosome 12 gave essentially the same re-
sults (see below). In this report, we present data obtained from
karyotypically normal hES cells, mainly AR1-c1 hES cells, and
G-GFP (H1) and H9 hES cells as controls.
TheGPI-AP-Deficient hESCell Clones LackPIG-AmRNA
Wedirectly analyzed thePIG-A expression in normal andGPI-AP
deficient undifferentiated hES cells cultured under a feeder-free
condition with or without subsequent differentiation induction.
As compared to somatic cell lines and differentiated (teratoma-
derived) cells, undifferentiated normal (G-GFP) hES cells express
a low level ofPIG-AmRNA, as assayed by both conventional and
quantitative RT-PCR analyses (Figure 2). Notably, PIG-A mRNA
in AR1-c1 or AR2-c1 hES clone showed much a lower level than
that in G-GFP hES cells (Figures 2A and 2B), consistent with the
fact that the AR cells lack GPI-APs on cell surface. PIG-AmRNA
levels in differentiated progeny after BMP4 induction or embry-
oid body (EB) formation was elevated significantly in the parental
G-GFP cells, but remained low in AR1-c1 derivatives (Figure 2).
Quantitative RT-PCR analysis using a different primer set re-
vealed that the PIG-A mRNA level in the differentiated AR1-c1
cells is 450- and 52-fold lower than that in the parental G-GFP
hES cells, after BMP4-induced differentiation or EB formation
(Figure 2C). As expected, the AR1-c1 hES cells transducedwith a PIG-A expressing vector expressed PIG-A mRNA at a
very high level before or after differentiation (Figures 2A–2C).
Northern blot further confirmed the RT-PCR results: PIG-A
mRNA of any size was not detected in AR1-c1 cells before the
transgene restoration, whereas G-GFP cells expressed the
wild-type (3.6 kb) PIG-A transcript (Figure 2D). This is consis-
tent with the fact that we did not detect any genetic mutation
in all 6 exons and intron/exon junctions of the PIG-A gene in ei-
ther AR hES clone after extensive sequencing (data not shown).
The exact mechanisms of the observed PIG-A deficiency in
the AR hES clones remain to be fully determined; nonetheless,
we have obtained two PIG-A null hES clones lacking GPI-APs,
permitting us to examine the roles of GPI-APs using hES cell-
initiated developmental models.
Two GPI-AP-Deficient hES Clones Formed
Morphologically Normal EBs and Hematopoietic
Cells In Vitro
We next examined differentiation potentials of both AR1-c1 and
AR2-c1 clones, in comparison with the parental G-GFP hES
cells. Similarly to other normal hES cells, G-GFP hES cell aggre-
gates cultured in suspension (with serum factors) developed into
more structured (cystic) EBs. By day 8, enlarged EBs showed
visible cavity. These cystic EBs are more evident by day 10–15
(Figure 3A). AR1-c1 and AR2-c1 both formed morphologically
normal EBs at a rate similar to G-GFP hES cells (Figure 3A). Cells
derived from EBs up to day 15 were further analyzed. The ubiq-
uitously expressed GPI-APs, CD55 and CD59, remained absent
in EB-derived cells from AR1-c1 and AR2-c1 clones (Figure 3B).
This contrasts to previous studies that mES cells lacking PIG-A
formed EBs poorly (Dunn et al., 1996).
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entiation from the Parental and Two Indepen-
dent PIG-A-/GPI-AP-Deficient hES Cell Clones
(A) Three ES cell types were cultured in suspension as
aggregates to form EBs. The morphology and num-
bers of EBs were monitored daily for 15 days. The
EB morphology is better illustrated by constitutively-
expressed GFP signal. The rate as well as morphology
of EBs by three hES cell types was similar.
(B) Confirmation of the GPI-AP deficiency in EB-de-
rived cells. Antibodies recognizing CD55 and CD59
were mixed and used to stain single-cell suspension.
(C) RT-PCR analysis ofmarker gene expression before
and after EB formation at day 10. As expected, Nanog
expression in G-GFP control cells (sample 1) is high
in undifferentiated ES cells (undiff. ES) and visibly
reduced after spontaneous differentiation by EB for-
mation (EB). The gene expression of differentiated
markers such as AFP (endoderm), CD34 (mesoderm),
MSI 1, and PAX6 (ectoderm) were significantly ele-
vated as compared to undifferentiated ES cells.
AR1-c1 (sample 2) showed similar pattern to the
G-GFP control, as did the AR1-c1 cells expressing
PIG-A transgene (sample 3).
(D) RT-PCR analysis of a marker gene expression for
trophectoderm. hCGa expression from AR1-c1 hES
cells (sample 2) failed to elevate after EB formation
but was restored by PIG-A transgene expression.
See more data by real-time quantitative RT-PCR in
Figure S3.To examine the differentiation commitment to the 3 embryonic
germ layers, we analyzed the acquired expression of lineage
specific markers in EB-derived cells. The expression of AFP (en-
doderm), PAX6 and Musashi (MSI) 1 (ectoderm), and CD34 (me-
soderm) marker genes within the EBs from AR1-c1 hES cells
were comparable or moderately higher than within the G-GFP
EBs (Figure 3C). Similar results were obtained using quantitative
RT-PCR with different primer sets and detection probes (Fig-
ure S3). Although interesting differences were observed between
two groups (such as levels of CD34 and NANOG expression),
it appears AR1-c1 cells are, overall, competent in differentiation
commitment to the three embryonic germ layers at this early
stage. We further analyzed hematopoietic differentiation of
AR1-c1 and AR2-c1 hES cells after EB formation (Figure S4).
The level of produced CD34+ cells (hematopoietic and/or endo-
thelial) or colony-forming hematopoietic progenitor cells from
AR1-c1 clone appears comparable to the G-GFP control or the
isogenic control where the PIG-A expression is restored by a
transgene (Figure S4). Our results indicate that GPI-APs in hES
cells are dispensable for entry to the 3 embryonic germ layers
or the hematopoietic lineage commitment. The effects of GPI-
APs on the progression along ectoderm and endoderm lineages
are under investigation.
Defect in Trophoblast Differentiation
from GPI-AP-Deficient hES Cells
Unlike mES cells, hES cells readily gave rise to trophoblasts after
spontaneous or induced differentiation (Xu et al., 2002; Pera
et al., 2004; Gerami-Naini et al., 2004). So, we also examined
the expression of trophoblast or trophectoderm (TE) markers
from the same EBs (Figure 3). To our surprise, the expression
of human chorionic gonadotropin alpha (hCGa), a TE marker,348 Cell Stem Cell 2, 345–355, April 2008 ª2008 Elsevier Inc.failed to elevate after EB formation from AR1-c1 hES cells (Fig-
ure 3D). Similar results were obtained with the expression of
CDX2 (Figure S3), a marker of TE lineage in early embryos
(Strumpf et al., 2005; Niwa et al., 2000, 2005). The defect ap-
pears specifically due to the PIG-A and GPI-AP deficiency
because the failure to turn on hCGa and CDX2 expression
in AR1-c1 cells can be fully rescued by the PIG-A transgene
(Figure 3D; Figure S3).
To confirm the link between defects of GPI-APs and tropho-
blast formation, we also used a second method of trophoblast
formation from hES cells. The addition of exogenous BMP4 or
a related family member to monolayer culture of hES cells that
are cultured otherwise as undifferentiated cells (with feeder-de-
rived factors and bFGF) rapidly induced morphological changes
(Xu et al., 2002). Consistent with the previous report, we found
that G-GFP hES cells differentiated into cells resembling tropho-
blasts when exogenous BMP4 (10–50 ng/ml) were added for
5 days. Nearly all the cells flattened after 7–10 days, and hCG
hormone was readily detected as previously reported (Xu et al.,
2002). Ten days after BMP4 induction of G-GFP hES cells,
NANOG mRNA decreased and hCGa mRNA increased over
100-fold (Figure S3 and Figure 4A). However, hCGa gene ex-
pression in AR1-c1 hES cells failed to elevate after BMP4 treat-
ment. Similar patterns were observed with other trophoblast
markers such as hCGb and CDX2 (Figure 4A). The deficiency
of hCGa gene upregulation was rescued by the PIG-A transgene
(Figure 4B). We further confirmed the deficiency of trophoblast
formation at the protein level: the b subunit of secreted hCG in
the AR1-c1 group was absent (Figure 4C). The lack of tropho-
blast formation in AR1-c1 cells after BMP treatment was further
confirmed by the lack of induced placenta-cadherin (CDH3) and
TROMA-I that are normally accompanied with trophoblast
Cell Stem Cell
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tion of Normal G-GFP hES Cells, but Not AR1-c1
hES Cells, Lacking GPI-APs
The parental (G-GFP) and AR1-c1 hES cells were cultured
under a feeder-free condition and treated with BMP4
(50 ng/ml) for 10 days. Then, cells were harvested for
RT-PCR analyses (A and B) after the conditioned medium
was collected and used to detect hCG hormone by ELISA
(C). (A) Quantitative RT-PCR for trophoblast markers such
as hCGa, hCGb, and CDX2. *Undetectable as in undiffer-
entiated hES cells after 40 cycle PCR. Profiles of the gene
expression of other markers (such as NANOG, AFP, CD34,
and PAX6) after BMP4 induction are shown in Figure S3.
(C) Conventional RT-PCR using a different primer set for
hCGa (as in Figure 3D) and a specific primer set for PIG-A
as in Figure 2A. RNA from undifferentiated ES cells (undiff.
ES) or after BMP4 induction (BMP4 induced) from either
G-GFP (sample 1) or AR1-c1 (sample 2) hES cells was
used. In addition, we also included AR1-c1 derivatives in
which a PIG-A transgene is expressed (sample 3) in this
experiment. (D) Immunofluorescent staining for trophecto-
derm markers placenta-cadherin (upper row, a and b) and
TROMA-I (lower row, c and d) from the differentiated
G-GFP (left) and AR1-c1 cells (right) 11 days after BMP4
induction. The presence of antigen is visualized by anti-
mouse IgG conjugated with Alexa 595 (red) and nuclei
were stained by DAPI (blue). While the trophectoderm
marker induction is obvious in the differentiated G-GFP
cells, it is much lower in the GPI-AP-deficient AR1-c1
cell population.differentiation (Niwa et al., 2005; Brulet and Jacob, 1982), as
seen with G-GFP parental hES cells (Figure 4D).
BMP Signaling Is Impaired in AR1-c1 hES Cells
Lacking GPI-APs
We next investigated underlying mechanisms of defective
trophoblast formation from GPI-AP-deficient hES cells by em-
ploying the BMP4-mediated differentiation system. BMP4 func-
tions through BMP receptor-mediated intracellular signaling by
activating one or more members of SMAD family (SMAD 1, 5,
and 8) and other targets (Zhang and Li, 2005). Two BMP recep-
tors, type I and II, have been identified. Type II BMP receptors are
primarily involved in ligand binding and activating a BMP type I
receptor that has intrinsic serine/threonine kinase activity (Zhang
and Li, 2005). One of three type I BMP receptors, ALK2, ALK3
(BMPR-Ia), or ALK6 (BMPR-Ib), subsequently activates (phos-
phorylates) SMAD 1, 5, or 8 and other targets and turns on down-
stream signaling cascades. In conjunction with other transcrip-
tional factors, the BMP-activated SMAD complex modulates
the expression of an array of genes including four members of In-
hibitor of differentiation or Id genes (Hollnagel et al., 1999; Lopez-
Rovira et al., 2002; Ying et al., 2003). We found that in hES cells
the expression of human Id or ID genes (ID1 to ID4), especially
that of ID1 and ID2, is indeed activated immediately by BMP4,
but not by TGFb (Figure S5). Our data extended the previous
report with the ID1 gene (Xu et al., 2005). The direct activation
of ID1 and ID2 promoters by BMP4 signaling was further con-
firmed in both H1 and H9 hES cell lines by a Luciferase (Luc)
reporter assay (Figure S5).
We next directly examined BMP4 signaling activation in AR1-
c1 hES cells using two assays. In the first assay, the Id1-Luc re-
porter was transfected into either AR1-c1 or G-GFP control hEScells followed by overnight BMP4 stimulation (Figure 5A). While
the exogenous BMP4 stimulates the reporter activity up to 12
fold in G-GFP cells in a dose-dependent manner, the stimulation
on GPI-AP-defective AR1-c1 cells could reach only 3 fold (Fig-
ure 5A). Notably, the PIG-A transgene expression in AR1-c1 cells
largely restored the BMP4-mediated activation in this assay as in
BMP4-induced trophoblast differentiation (Figure 5A). In the sec-
ond assay, we measured earlier events of BMP signaling activa-
tion bywestern blot. We used a specific antibody recognizing the
activated (phosphorylated) form of three highly related SMAD
proteins (SMAD 1/5/8) that are direct targets of activated BMP
receptors type I (BMPR-I) after BMP4 stimulation. Consistent
with previous reports, phosphorylated forms of SMAD 1/5/8
were low in undifferentiated hES cells before BMP4 induction
(Figure 5B). BMP4 induction drastically increased the level of
phosphorylated forms of SMAD 1/5/8 in G-GFP cells, but not
in AR1-c1 cells. Based on the results obtained from the two inde-
pendent assays, we conclude that BMP signaling is defective in
AR1-c1 cells, likely at the level of BMPR-I activation.
We also examined the requirement of BMP signaling for
trophoblast differentiation from a different hES cell line H9 using
a known BMP antagonist NOGGIN. As previously reported
(Xu et al., 2002), NOGGIN blocked BMP4-induced trophoblast
differentiation from H9 as well as H1 (G-GFP) hES cells in mono-
layer cultures. We next tested if NOGGIN could also prevent tro-
phoblast differentiation following EB formation (in the absence of
exogenous BMP). Ten days after EB formation from H9 hES
cells, undifferentiated markers such as NANOG decreased,
whereas lineage (differentiation) markers such as CDX2, hCGa,
and PAX6 increased (Figure S6). Increasing concentrations of
NOGGIN resulted in a sharp reduction of CDX2 and hCGa up-
regulation, but affected little on NANOG downregulation. In fact,Cell Stem Cell 2, 345–355, April 2008 ª2008 Elsevier Inc. 349
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Human ES Cells Lack GPI-Anchored Surface Proteinsthe upregulation of PAX6 (an ectoderm marker) was further en-
hanced with increased concentrations of NOGGIN. Mesoderm
marker upregulation following EB formation is less sensitive to
NOGGIN blocking (Figure S6). Taken together, we show that in
two distinct hES cell lines the dependency on BMP signaling
for trophoblast formation is greater than some other lineages.
Overexpression of an Activated BMPR-I Gene
in AR1-c1 hES Cells Restored BMP Signaling
and Trophoblast Differentiation
Using the unique AR1-c1 (H1) hES cells, we examined if the BMP
signaling as well as trophoblast differentiation could be restored
by the overexpression of an activated form of BMPR-I in the de-
ficient hES cells. We used an activated form of ALK3 (also known
as BMPR-Ia) gene which contains amutation (Q233D), rendering
enhancedactivationwithout orwith lessBMP ligands (Chenet al.,
1998). We transfected AR1-c1 and G-GFP cells with such an
ALK3 vector together with the Id1-Luc reporter, and treated cells
Figure 5. BMP Signaling Activation Is Significantly Reduced in
AR1-c1 hES Cells Due to the PIG-A and GPI-AP Deficiency
(A) BMP4 signaling activation in G-GFP or AR1-c1 hES cells was measured by
a Luciferase reporter (Id1-Luc) controlled by the Id1 gene promoter. Six hours
after transfection of the reporter plasmid, cells were stimulated with various
concentration of BMP4 for 20 hr and harvested. The Id1-Luc activity was mea-
sured, normalized, and calculated relative to that of G-GFP without BMP4
stimulation (defined as 1). The normalized mean and SD (nR 5) were plotted.
In one experiment, the Id1-Luc activity in AR1-c1 hES cells that have been
transduced with PIG-A transgene was also measured before and after BMP
induction (n = 5). Combined from two experiments (Sn = 7), the mean of the
reconstituted AR1-c1/PIG-A cells is statistically greater than the AR1-c1 cells
(p < 0.05) and insignificant from G-GFP hES cells (p > 0.05).
(B) Western blot to detect the phosphorylated (activated) form of three highly
related SMAD proteins (1/5/8) without or with BMP4 induction. G-GFP (1) or
AR1-c1 (2) hES cells were treated with BMP4 for 6 hr, and cell lysates were
analyzed by western blotting, using purified specific antibodies recognizing
the phosphorylated SMAD1/5/8. After stripping, the blot was reprobed by a
specific antibody recognizing the housekeeping protein GAPDH.350 Cell Stem Cell 2, 345–355, April 2008 ª2008 Elsevier Inc.with or without BMP4 after transfection (Figure 6A). Twenty hours
after BMP4 induction following cotransfection with the control
plasmid, the BMP4 signaling measured as the Id1-Luc activation
was as expected: BMP4 (50 ng/ml) stimulated the reporter activ-
ity by14 fold in G-GFP cells, but only4 fold in AR1-c1 cells as
in Figure 5A. Transfection of the activated ALK3 gene to AR1-c1
cells moderately stimulated the reporter in the absence of exog-
enous BMP4. When BMP4 was added, however, the level of
BMP4 activation in AR1-c1 cells with ALK3 transfection is com-
parable to that of G-GFP cells without transfection (Figure 5A)
or transfected by a control plasmid (Figure 6A), evenwith a trans-
fection efficiency of 40%–50%.
To testwhether the overexpressionof the activatedALK3 trans-
gene in AR1-c1 cells can also restore trophoblast differentiation,
we monitored upregulation of the hCGa gene expression (Fig-
ure 6B). After two rounds of transfection (at day 0 and 2) with the
ALK3 or control vector, G-GFP or AR1-c1 cells treated with or
without BMP4 were harvested at day 5. The levels of hCGa gene
expression in the control vector-transfected cells were similar to
the mock-transfected cells as expected: the hCGa gene expres-
sion was only turned on after BMP4 induction, and it was much
weaker in AR1-c1 cells even after BMP4 induction. When AR1-
c1 hES cells were transfectedwith the activated ALK3 gene, how-
ever, the BMP4-mediated hCGa gene upregulation is restored
(Figure 6B). The presence of acquired TROMA-I protein, a tropho-
blastmarker, further supported that trophoblast formation in AR1-
c1 hEScells can be restored by the activatedALK3gene transfec-
tion (Figure 6C). Similar results were observed with an activated
form (Q203D) of ALK6 also known as BMPR-Ib (Chen et al.,
1998; data not shown). Based on BMPR-I reconstitution assays,
weconclude thatoneormoreGPI-APsarecritical for full activation
of BMP4 receptors and human trophoblast differentiation.
Overexpression of Membrane-Bound DRAGON
in AR1-c1 hES Cells Also Restored BMP Signaling
and Trophoblast Differentiation
We then focused on a group of GPI-APs that are recently identi-
fied as accessory coreceptors for BMP2 and BMP4 (Samad
et al., 2005; Babitt et al., 2005, 2006). This GPI-AP subfamily
include 3 structurally related proteins called Repulsive Guidance
Molecule a (RGMa), DRAGON (also called RGMb), and HFE2
(RGMc). It has been demonstrated that GPI-anchored (but
not soluble) RGM proteins facilitate the binding of a BMP2 or
BMP4 ligand to one or more forms of type II BMP receptors
and potentiate the downstream BMP signaling (Samad et al.,
2005; Babitt et al., 2005, 2006; Xia et al., 2007).
By RT-PCR, we confirmed the gene microarray data that
DRAGON and, to a lesser extent, RGMa gene are expressed in
all the hES cells used (Table S1; Figure S7A). Similar to previous
reports with other cell types, soluble forms of DRAGON or RGMa
proteins purchased did not activate BMP4 signaling in hES cells
(data not shown). Among several approaches we tested, we
observed that transgene expression of a modified DRAGON
cDNA in AR1-c1 hES cells made functional constitution as did by
the PIG-A transgene (Figure 7). Because the PIG-A deficiency
results inaposttranslational defect forGPI-APs, transgeneexpres-
sion of the wild-type DRAGON cDNA (like the endogenous gene)
could not produce a GP-anchored product on cell surface, even
theprecursorprotein ismade incytoplasm.Therefore,weexplored
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DRAGON using the coding sequence of the mature DRAGON
domain fused toa transmembrane (TM)domainprovidedbyanex-
pressionvectorcalledpDisplay (FigureS7B).Whenoverexpressed
in 293T cells, the pDisplay vector encoding the fusion TM protein
(DRAGON) indeed directed the cell surface expression as mea-
sured by flow cytometry (Figure S7) or immunostaining (data
not shown). When the same vector was used to transfect AR1-c1
hES cells as we did previously with the ALK3 vector (Figure 6A),
the DRAGON vector reconstituted the BMP4-mediated Id1-Luc
activation (Figure 7A). Similarly, serial (transient) transfection of
DRAGONvector inAR1-c1 cells resulted in the upregulation of tro-
phoblast marker expression at day 5, such as hCGa by RT-PCR
(Figure 7B) and TROMA-I by antibody staining (Figure 7C). Finally,
we generated knockdownH9 hES cells that are stably transduced
with a lentiviral vector expressing a small hairpin RNA targeting
the DRAGON or RGMa gene (Figure S8). The H9 hES cells with
reduced DRAGON or RGMa expression were impaired in BMP4-
mediated Id1-Luc activation, hCGa upregulation, and acquired
TROMA-I expression after BMP stimulation, a phenotype similar
to AR1-c1 (H1) hES cells lacking all the GPI-APs.
DISCUSSION
Specific gene inactivation in hES cells may provide novel genetic
and developmental models for human diseases. Previously, two
Figure 6. Transient Transfection of an Activated BMP-RI
Gene Restored the BMP Signaling and Trophoblast Forma-
tion
(A) G-GFP or AR1-c1 hES cells were transfected with an activated
ALK3 gene or control vector, together with the Id1-luciferase reporter
plasmid and the EF.lacZ as in Figure 5A. Six hours after transfection,
cells were stimulated in the absence () or presence (+) of BMP4 (50
ng/ml) for 20 hr and harvested. The Id1-luciferase activity was mea-
sured, normalized by the lacZ activity, and calculated relative to the
level without BMP4 stimulation (defined as 1) for either G-GFP or
AR1-c1 hES cells. The normalized mean and SD values from 3 inde-
pendent experiments were combined and plotted (Sn = 8). The differ-
ence of the ALK3-transfected, BMP4-activated AR1-c1 cells versus
any of other 3 AR1-c1 groups is significant (p < 0.05).
(B) Human CGa gene expression in AR1-c1 cells after ALK3 transfec-
tion and BMP4 stimulation. G-GFP (samples 1) or AR1-c1 (samples 2)
hES cells in pair were transfected with the activated ALK3 gene or
control vector at day 0 for 6 hours and treated in the absence or pres-
ence of BMP4 (50 ng/ml) for 2 days. Two days after, the same treat-
ment was repeated. After a total of 5 days, various types of transfected
cells were either harvested for RT-PCR (B) or fixed for immunostaining
(C). Human hCGa gene expression was measured by RT-PCR as in
Figure 3D and Figure 4B.
(C) TROMA-I staining of the double-transfected hES cells at day 5 as in
(B). Scale bar, 50 mm.
reports described the inactivation of the X-linked
HPRT gene in a XY hES cell line as a potential model for
Lesch-Nyhan disease (Zwaka and Thomson, 2003;
Urbach et al., 2004). Although these HPRT knockout
hES cells indeed lacked the encoded enzyme, the biolog-
ical or pathological consequences remain to be deter-
mined (Zwaka and Thomson, 2003; Urbach et al., 2004).
In contrast, the present study reports the establishment
of hES cells lacking PIG-A gene expression, resulting in clonal
hES cells deficient of a group of cell surface (GPI-anchored) pro-
teins including APase, Cripto, and CD90. Our data demonstrate
that GPI-APs are not essential for self-renewal of hES cells in
culture, although they are preferentially expressed in undifferen-
tiated hES cells.
PIG-A- and GPI-AP-deficient hES cells also appeared normal
in the initial differentiation into derivatives of the three embryonic
germ layers. Among mesoderm-derived lineages we examined,
the production of CD34+ hematopoietic precursor cells in vitro
from GPI-AP-deficient hES cells also appeared normal, thus
allowing us to next examine the effect of PIG-A and GPI-AP
deficiency on downstream steps of hematopoiesis. In addition,
further neural cell development may require multiple GPI-APs
based on previous mouse studies. The availability of hES cells
lacking PIG-A and GPI-APs and their derivatives expressing an
inducible PIG-A transgene may help us to study roles of various
GPI-APs in the development of human cell types other than
trophoblasts as demonstrated in this study.
We unexpectedly found that PIG-A-/GPI-AP-deficient hES
cells failed todifferentiate into trophoblasts.Oneof theprominent
innovations in early mammalian embryogenesis is the formation
of the trophoblast, the specialized tissue that subsequently forms
trophic interface between the embryo and the mother. The first
overt differentiation event inmammalian embryos is the formation
of TE (the outer epithelial layer of theblastocyst),which goeson toCell Stem Cell 2, 345–355, April 2008 ª2008 Elsevier Inc. 351
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trophoblast stem (TS) cell lines, can only commit to the cell fate
of trophoblastic tissues. In contrast, the inner cell mass in the
mouse blastocyst maintains pluripotency and later develops
into epiblasts and then the three embryonic germ layers andother
extraembryonic tissues. Numerous studies showed that mES
cells, derived from the inner cell mass of mouse blastocysts,
rarely form trophoblasts naturally. An exception is when the level
of master transcriptional factors is altered by genetic manipula-
tion, e.g., by enforced reduction ofOct4expression orCdx2over-
expression (Niwa et al., 2000, 2005; Zhang et al., 2006). It was
recently reported, however, that some mES cell lines, but not
others, can differentiate into trophoblasts (or TS cells) at a low
level together with many mesodermal cells when cultured on
collagen IV (Schenke-Layland et al., 2007). It remains to be deter-
mined whether hES cells can also be induced to trophoblasts or
TS cells by culturing on collagen IV or under other conditions, in
BMP-dependent or -independent manners.
It is now clear that most, if not all, hES cell lines readily form
trophoblasts and other extraembryonic lineages after differenti-
ation induction.With the BMP4 addition into a feeder-free culture
condition for R 5 days, undifferentiated hES cells cultured as
a monolayer differentiate preferentially into trophoblasts
Figure 7. Transient Transfection of a Transmembrane
Form of DRAGON Restored the BMP Signaling Activation
and Trophoblast Formation
(A) G-GFP or AR1-c1 hES cells were transfected with the engi-
neered DRAGON vector or the control pDisplay vector, together
with the Id1-luciferase reporter plasmid and the EF.lacZ as in
Figure 6A. Six hours after transfection, cells were stimulated in
the absence () or presence (+) of BMP4 for 20 hr and harvested.
The Id1-luc activity wasmeasured, normalized by the lacZ activity,
and calculated relative to the level without BMP4 stimulation (de-
fined as 1) for each cell type. The normalized mean and SD values
(n = 4) were plotted. The difference between Samples A and B
is significant (p < 0.05). (B) Human CGa gene expression in
AR1-c1 cells after DRAGON transfection and BMP4 stimulation.
G-GFP (sample 1) or AR1-c1 (sample 2) hES cells in pair were
transfectedwith the DRAGONor control vector at day 0 for 6 hours
and treated in the absence or presence of BMP4 (50 ng/ml) for
2 days. Two days after, the same treatment was repeated. After
a total of 5 days, various types of transfected cells were either
harvested for RT-PCR (B) or fixed for TROMA-I immunostaining
(C). Scale bar, 50 mm.
(Xu et al., 2002). This unique feature of hES cells
helped us to discover that one ormore GPI-APs are re-
quired for trophoblast differentiation. Mechanistically,
our data reveal that GPI-AP-mediated high-level
BMP activation is required for human trophoblast
formation. It is of interest to determine whether this
mechanism also holds true in other placenta-bearing
mammals such as mice. It is possible that species dif-
ferencemay exist between humans andmice in this re-
gard as seen between hES and mES cells (Ginis et al.,
2004). For example, BMP signaling mediated by Alk3
(Bmpr-Ia) is required for derivation of mES cells (Qi
et al., 2004). BMP4 also cooperate with LIF to maintain
the proliferation of undifferentiated mES cells (Ying
et al., 2003; Qi et al., 2004). However, adding BMP4 stimulates
differentiation of hES cells under culture conditions that other-
wise promote self-renewal of hES cells as shown here and in pre-
vious studies (Xu et al., 2002, 2005; Dravid et al., 2005). Blocking
endogenous BMP (and those made by feeder cells) by soluble
BMP antagonists enhanced the self-renewal of hES cells (Pera
et al., 2004; Xu et al., 2005). Thus, it appears that in undifferenti-
ated hES cells BMP activation is kept at an inactive or low level.
This is in a sharp contrast to mES cells where BMP signaling is
required for their self-renewal (Ying et al., 2003; Qi et al., 2004).
However, hES cells can respond to BMP stimulation acutely
and differentiate.
It has been known that some cell-surface proteins (also called
as type III receptors) are important to the signaling by some
members of the TGFb/Activin/Nodal/ BMP ligand superfamily,
positively regulating ligand activities (Zhang and Li, 2005). For
example, cell-surface protein b-glycan or CD105 (endoglin) func-
tions as a coreceptor for TGFb. Cripto, another GPI-AP, func-
tions as a coreceptor for Nodal that utilizes activin receptors
(Minchiotti et al., 2000). Very recently, DRAGON and related pro-
teins RGM were identified as coreceptors for BMP2 and BMP4
(Samad et al., 2005; Babitt et al., 2005, 2006). Notably, DRAGON
and other RGM members such as RGMa and RGMc (HFE2) are352 Cell Stem Cell 2, 345–355, April 2008 ª2008 Elsevier Inc.
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protein, although not absolutely essential for BMP signaling,
may help to sensitize all or some forms of type II BMP receptors
(BMPRII, actRIIA, or ActRIIB) to the binding of a BMP ligand, thus
enhancing or extending downstream BMP (type I receptor)
signaling (Xia et al., 2007). Among these 3 RGMs, DRAGON/
RGMb is expressed in mouse E2.5 preimplantation embryos
and in later stages of embryos from E7 to E17 (Samad et al.,
2005). DRAGON is also found expressed in human reproductive
axis (Xia et al., 2005). We found that DRAGON and, to a lesser
extent, RGMa genes are expressed in hES cells and postulated
that the defect of GPI-AP-deficient (AR1-c1) hES cells in BMP
signaling is primarily due to the lack of a DRAGON/RGM (GPI-
AP) subfamily member that serves as a coreceptor for BMP4.
To express a functional form of this subfamily on the surface of
PIG-A-/GPI-AP-deficient AR1-c1 hES cells that are defective
posttranslationally and lack all the GPI-APs, we made a novel
DRAGON cell-surface protein by fusing the mature DRAGON
domain with a transmebrane domain. As predicted, the over-
expression of the engineered cell surface DRAGON protein
(DRAGON) restored both high-level BMP activation and tropho-
blast differentiation (Figure 7) as did an activated type I BMP
receptor (ALK3 or ALK6) gene vector (Figure 6). Conversely,
knockdown DRAGON or RGMa gene expression in H9 hES cells
(Figure S8) phenocopied the observation with AR1-c1 (H1) hES
cells. Based on these data, we suggest that cell surface forms
of DRAGON/RGM protein family play a critical role for high-level
activation of BMP signaling in hES cells, which is in turn critical
for trophoblast differentiation. How the members of DRAGON/
RGM GPI-AP subfamily modulate or oppose related signaling
such as those mediated by Activin/Nodal remains to be deter-
mined (Besser, 2004; James et al., 2005; Xia et al., 2007). Our
approach of constructing a transmembrane form of GPI-APs
such as DRAGON and reconstituting in AR1-c1 hES cells will
likely help to delineate the first step of requirement for other
GPI-APs during development using hES cell initiated develop-
mental systems.
It is generally believed, based on mouse and other lower or-
ganism models, that mesodermal induction is dependent on
BMP signaling (Hogan, 1996). However, mesodermal differenti-
ation in AR1-c1 cells lacking GPI-APs appears normal (e.g.,
CD34 gene expression in Figure S3 and CD34+ cell production
in Figure S4), whereas trophoblast differentiation fails due to
the reduced level of BMP signaling. One hypothesis is that
GPI-anchored coreceptors such as DRAGON are only critical
to the full activation of BMP signaling and, in turn, trophoblast
or TE formation. This hypothesis then easily explains the fact
that mesoderm induction was not affected in GPI-AP-deficient
AR1-c1 hES cells. This hypothesis is also supported by gene
array data that BMP ligands (such as BMP4) and downstream
target genes (such as human ID2 and eHAND/Hand1) are ex-
pressed significantly higher in human TE tissues versus inner
cell mass (Adjaye et al., 2005) and also higher (such as Id2)
in mouse TS cells versus mES cells (Tanaka et al., 2002). The
generality of this novel hypothesis, such as in mice and other
placental-bearing mammals, however, remains to be fully in-
vestigated. The present study highlights the excitement that
hES cells provide an unprecedented and much-needed re-
search tool for understanding the development and functionof human cells and tissues in normal and pathological
processes.
EXPERIMENTAL PROCEDURES
Human ES Cell Culture
The H1 and H9 cell lines are obtained fromWiCell Research Institute, Inc. (Wis-
consin, MI) and propagated as previously described (Zhan et al., 2004; Dravid
et al., 2005; Zhou et al., 2007). For the feeder-free culture and proaerolysin
selection, undifferentiated hES cell clumps were passaged onto Matrigel
(BD Biosciences, 1/30 dilution)-coated tissue plates and cultured in primary
embryonic fibroblast (pMEF)-conditioned medium (Dravid et al., 2005). An
H1 hES cell preparation (G-GFP, nonclonal) that stably expresses GFP after
lentivial vector transduction (Dravid et al., 2005; Zhou et al., 2007) was used
as the starting cell population to select GPI-AP-deficient cells by proaerolysin
selection. Cells were incubated with 500 nM proaerolysin (Protox Biotech, Vic-
toria, Canada) at 37C for 30 min and cultured under the feeder-free condition
for one passage (5–7 days). The (pro-)aerolysin-resistant (AR) hES cells were
expanded and monitored for the presence or absence of GPI-APs such as
Thy-1/CD90 on cell surface. A detailed procedure of how we established
two independent clones (AR1-c1 and AR2-c1) is described in Table S2.
Gene transduction of AR hES cells by an inducible lentiviral
vector (iDuet101/PIG-A) was previously described (Zhou et al., 2007). The
karyotyping was conducted (300–400 bands, 20 mitotic spreads) as previous
described (Zhan et al., 2004).
Induced hES Cell Differentiation
Various hES cell lines cultured under the feeder-free condition were used for
embryoid formation (in suspension, with 20% fetal bovine serum) as previously
described (Zhan et al., 2004). For BMP4 induced differentiation, hES cells were
cultured under the feeder-free condition (on Matrigel, serum-free and with
pMEF-conditioned medium) in the presence of exogenous BMP4 (Xu et al.,
2002). Unless otherwise indicated, 50 ng/ml BMP-4 (R&D Systems) was
used. The supernatant was collected at day 10 for a human chorionic gonad-
otrophin (hCG) ELISA (with an antibody specific to the hCGb) performed by
Johns Hopkins Hospital. The BMP4-treated cells were analyzed subsequently
by either RT-PCR or immunostaining.
Immunostaining
Adherent hES cells before or after differentiation were fixedwith PBS containing
4% paraformaldehyde for 20min at RT. Following blocking of nonspecific bind-
ing with 4% goat serum, the cells were incubated with mouse monoclonal (IgG)
antibodies recognizing alkaline phosphatase (TRA-2-49), SSEA-4 (MC-813-70),
and TROMA-1 (Developmental Studies HybridomaBank, IowaCity, IA) or Cripto
and placenta-Cadherin/CDH3 (both from R&D Systems). The stained cells were
visualized by anti-mouse goat IgG conjugated with Alexa 594 or Alexa 555
(Invitrogen). For intracellular staining of TROMA-I and Cripto, fixed cells were
first permeablized by treatment with 0.1% Triton X-100 and 1%BSA for 45min.
Flow cytometric (FACS) analysis was used as previously described (Zhou et al.,
2007).
Analysis of Gene Expression by RT-PCR
Total RNA isolated from various hES cell populations before and after induced
differentiation was analyzed as before (Dravid et al., 2005). Primers used for
semiquantitative PCR are listed in Table S3. For quantitative (real-time) RT-
PCR, specific primers and probes were purchased from Applied Biosystems
(Foster City, CA) and used as described before (Dravid et al., 2005). Total
RNA isolated from normal hES cell-derived teratoma (consisting of mixed
cell population) was used to normalize between various hES cell samples be-
fore or after differentiation. After normalization to the level of the b-actin gene,
the expression level of each gene is plotted in a log scale relative to the level of
the given gene expression in teratoma defined as 100.
Northern Blot
RNA (10 mm total) of undifferentiated and BMP4-induced hES cells were
denatured, separated by electrophoresis, and transferred onto Hybond-N filter
(Amersham Biosciences, Piscataway, NJ). After crosslinking RNA by UV
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labeled PIG-A gene probe in ULTRAhyb Hybridization Buffer (Ambion, CA)
overnight. After striping, the filter was reprobed with the b-actin gene probe.
Western Blot
The protein extracts from hES cells ± BMP4 induction (50 ng/ml for 6 hr) were
made and separated by 8%–16% SDS-PAGE (Bio-RAD Laboratories, Hercu-
les, CA) and were transferred onto Hybond-P membrane (Amersham Bio-
sciences). Purified antibodies recognizing phosphorylated SMAD 1/5/8 (Cell
Signaling Technology Inc.) were used (James et al., 2005). The purified rabbit
antibody recognizes phosphorylated SMAD 1/5/8 at SMAD 1 (S463/465),
SMAD 5 (S463/465), and SMAD 8 (S426/428). After striping, the filter was re-
probed with an antibody recognizing GAPDH, a housekeeping protein used
as an internal control.
Construction and Use of a Vector Expressing a Transmembrane
Form of DRAGON Protein
To express the DRGON/RGMb molecule on the cell surface of AR1-c1 hES
cells deficient in PIG-A and all the GPI-APs, we had to engineer a chimeric
protein in which the mature form of DRAGON peptide (without the C-terminal
region that should be cleaved by theGPI anchoring process) is fused to a trans-
membrane (TM) domain. The cDNA encoding the mature form of human
DRAGON/RGMB (NP_001012779, from the 87th to 452th amino acids, lacking
the 26 amino acids at theC terminus) is cloned and inserted into the expression
vector called pDisplay (Invitrogen) at the BglII and Sac II sites (Figure S7B). This
allows in-frame fusion of DRAGON mature peptide to the TM domain of
a PDGF receptor, resulting in a TM called DRAGON. The cell-surface expres-
sion of DRAGON from the pDisplay-based vector is shown in Figure S7.
Transient Transfection of hES Cells to Measure BMP4-Induced
Signaling or Restoration
We used the reporter plasmid in which the luciferase gene is controlled by the
BMP-responsive element from the Id1 promoter (Id120-Luc) (Lopez-Rovira
et al., 2002) or the Id2 promoter (from Dr. Xiao-Hong Sun, Oklahoma Medical
Research Foundation). Human ES cells plated on Matrigel-coated 24-well
plates were transfected by lipofectamine 2000 as previously described (Dravid
et al., 2005). In short, 0.6 mg Id120-Luc plasmid and 0.2 mg EF.lacZ plasmid
were added into transfection mixture (0.1 ml) and added to 0.5 ml culture
medium. Six hours after transfection, hES cells were treated with various
concentrations of BMP4. After an additional 24 hr, transfected cells were lysed
and normalized lucferase activities were measured (Dravid et al., 2005).
We also cotransfected AR1-c1 and G-GFP hES cells by a plasmid vector
expressing an activated form of ALK3 (Q233D) or ALK6 (Q203D) gene (Chen
et al., 1998) or from the pDisplay-based DRAGON vector. A mixture of
0.3 mg of an expression vector and 0.3 mg Id120-Luc reporter, plus 0.2 mg
EF.lacZ plasmid, was used (S = 0.8 mg per well). Human ES cells under the
feeder-free conditions were transfected by either ALK3 or ALK6 expression
vector at day 0 for 6 hr and then treated with or without BMP4 (50 ng/ml).
BMP4-induced Id1-Luc activities were measured 20 hr after. For reconstitu-
tion of trophoblast formation in AR1-c1 cells, 0.8 mg of the activated ALK3
or pDisplay-based DRAGON vector was used to transfect hES cells per well
in 24-well plates. We repeated the procedure 48 hr later. By day 5, cells
were either harvested to RT-PCR analysis for elevated expression of tropho-
blast genes or fixed for staining by TROMA-I.
Statistical Analysis
Data plotted are typically expressed as mean ± standard deviation (SD). Sta-
tistical analysis was performed using GraphPad Prism version 4.0 (GraphPad
Software, San Diego, CA). Significance of differences was examined using the
Student’s t test (two-sided, unequal variance), or nonparametric Mann-Whit-
ney rank sum test when sample sizes were smaller. It is considered significant
if p value is% 0.05.
SUPPLEMENTAL DATA
The Supplemental Data include three tables and eight figures and can be found
with this article online at http://www.cellstemcell.com/cgi/content/full/2/4/
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